A consortium of Carlyle and PAI Partners to acquire Theramex
Theramex is a leading global speciality pharmaceutical company dedicated to women and their health which is headquartered in London.
Theramex is a leading global speciality pharmaceutical company dedicated to women and their health which is headquartered in London.
Under PAI’s ownership, Refresco has established a leading presence in the North America market, reinforced its strong position in Europe, and completed an ambitious buy-and-build strategy.
PAI Partners (“PAI”), a pre-eminent private equity firm, through its fund dedicated to mid-market opportunities, PAI Mid-Market Fund (“PAI MMF”), […]
Under PAI’s ownership, Asmodee has grown significantly, displaying solid double-digit organic growth while pursuing a value-accretive M&A strategy with 23 acquisitions completed.
Veonet is headquartered in Munich, Germany, and operates more than 190 ophthalmological clinics across Germany, the UK, the Netherlands and Switzerland.
PAI Partners (“PAI”), a pre-eminent private equity firm, today announces that it has reached an agreement to sell Atos Medical (“the Company”), a global market leader in supporting patients with a neck stoma, to Coloplast, a Danish multinational company that develops, manufactures, and markets medical devices and services related to ostomy, urology, continence, and wound care, for an enterprise value of c. €2.2 billion.